Export Ready — 

History of the discovery of the etiological agent of Kaposi’s sarcoma – Human Herpesvirus 8, and the role of the Instituto Adolfo Lutz in researching this infection/ disease

Bibliographic Details
Main Author: Caterino-de-Araujo, Adele
Publication Date: 2024
Format: Article
Language: por
Source: BEPA. Boletim epidemiológico paulista (Online)
Download full: https://periodicos.saude.sp.gov.br/BEPA182/article/view/41435
Summary: In the year in which we celebrate 30 years since the discovery of the etiological agent of Kaposi's sarcoma (KS), at the time named Kaposi's sarcoma-associated herpesvirus (KSHV), later Human Herpesvirus 8 (HHV-8), the author reports on the role of the Instituto Adolfo Lutz in searching this agent using molecular biology techniques, first in biopsy material stored in paraffin and then in blood, saliva and urine, and in the characterization of subtypes and viral variants of HHV-8 that circulated in patients with KS associated with AIDS (KS-AIDS) in São Paulo, and in indigenous populations from the Brazilian Amazon. Furthermore, in-house serological techniques (indirect immunofluorescence and Western blotting) were standardized using cell lines containing HHV-8 in the latent and lytic phases of viral infection as antigens, and serum or blood collected on filter membrane to search for specific antibodies. The best cost/benefit serological and molecular tests were selected and employed in epidemiological surveys, and HHV-8 prevalence rates were determined in different populations: children, health professionals, individuals with HIV/AIDS, female sex workers, endemic and epidemic KS cases, Amerindians, individuals with chronic renal failure, and the general population of Mozambique. Based on studies related to the pathogenesis of HHV-8 and its association with HIV/AIDS, it was observed that the antiretroviral therapy prevented the emergence of KS-AIDS cases in Brazil and suggested its use to control KS-AIDS in Africa. Finally, HHV-8 infection was confirmed in a case of peripheral effusion lymphoma (PEL). Keywords: KSHV, HHV-8, diagnosis, prevalence, viral subtypes, Kaposi’s sarcoma.
id SESSP_f8b6eb679f56d3b7ede7903dd59ae7a9
oai_identifier_str oai:ojs.periodicos.saude.sp.gov.br:article/41435
network_acronym_str SESSP
network_name_str BEPA. Boletim epidemiológico paulista (Online)
repository_id_str
spelling History of the discovery of the etiological agent of Kaposi’s sarcoma – Human Herpesvirus 8, and the role of the Instituto Adolfo Lutz in researching this infection/ diseaseHistórico da descoberta do agente etiológico do sarcoma de Kaposi – Human Herpesvirus 8 e a atuação do Instituto Adolfo Lutz na pesquisa dessa infecção/ doençaKSHVHHV-8diagnóticoprevalênciasubtipos viraissarcoma de KaposiIn the year in which we celebrate 30 years since the discovery of the etiological agent of Kaposi's sarcoma (KS), at the time named Kaposi's sarcoma-associated herpesvirus (KSHV), later Human Herpesvirus 8 (HHV-8), the author reports on the role of the Instituto Adolfo Lutz in searching this agent using molecular biology techniques, first in biopsy material stored in paraffin and then in blood, saliva and urine, and in the characterization of subtypes and viral variants of HHV-8 that circulated in patients with KS associated with AIDS (KS-AIDS) in São Paulo, and in indigenous populations from the Brazilian Amazon. Furthermore, in-house serological techniques (indirect immunofluorescence and Western blotting) were standardized using cell lines containing HHV-8 in the latent and lytic phases of viral infection as antigens, and serum or blood collected on filter membrane to search for specific antibodies. The best cost/benefit serological and molecular tests were selected and employed in epidemiological surveys, and HHV-8 prevalence rates were determined in different populations: children, health professionals, individuals with HIV/AIDS, female sex workers, endemic and epidemic KS cases, Amerindians, individuals with chronic renal failure, and the general population of Mozambique. Based on studies related to the pathogenesis of HHV-8 and its association with HIV/AIDS, it was observed that the antiretroviral therapy prevented the emergence of KS-AIDS cases in Brazil and suggested its use to control KS-AIDS in Africa. Finally, HHV-8 infection was confirmed in a case of peripheral effusion lymphoma (PEL). Keywords: KSHV, HHV-8, diagnosis, prevalence, viral subtypes, Kaposi’s sarcoma.No ano em que se comemora 30 anos da descoberta do agente etiológico do sarcoma de Kaposi (SK), à época denominado Kaposi’s sarcoma-associated herpesvirus (KSHV), posteriormente Human Herpesvirus 8 (HHV-8), a autora descreve como se deu esta descoberta e a atuação do Instituto Adolfo Lutz na pesquisa do agente usando técnicas de biologia molecular, primeiramente em material de biópsia estocado em parafina e depois em sangue, saliva e urina, e na caracterização de subtipos e variantes virais que circulavam em pacientes com SK associado à aids (SK-aids) em São Paulo, e em populações indígenas da Amazônia brasileira. Ademais, relata a padronização de técnicas sorológicas in house (imunofluorescência indireta e Western blotting) usando como antígenos linhagens celulares contendo HHV-8 nas fases latente e lítica da infecção viral, e soro ou sangue coletado em papel de filtro para pesquisa de anticorpos específicos. Os testes sorológicos e moleculares de melhor custo/benefício foram empregados em inquéritos epidemiológicos, e determinadas taxas de prevalência de HHV-8 em diferentes populações: crianças, profissionais da saúde, indivíduos com HIV/aids, profissionais do sexo feminino, casos de SK endêmico e epidêmico, ameríndios, indivíduos com insuficiência renal crônica, e população de Moçambique. Estudos relacionados à patogênese do HHV-8 e sua associação com o HIV/aids possibilitaram observar que a terapia antirretroviral (TARV ou HAART) preveniu o surgimento de casos de SK-aids no Brasil e sugerir seu uso para controle do SK-aids na África. Por fim, foi confirmada infecção por HHV-8 em um caso de linfoma de efusão em cavidades (peripheral effusion lymphoma, PEL). Palavras-chave: KSHV, HHV-8, diagnóstico, prevalência, subtipos virais e sarcoma de Kaposi.Coordenadoria de Controle de Doenças - Secretaria de Estado da Saúde de São Paulo2024-12-13info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionNão avaliado pelos paresapplication/pdfhttps://periodicos.saude.sp.gov.br/BEPA182/article/view/4143510.57148/bepa.2024.v.21.41435BEPA. Boletim Epidemiológico Paulista; Vol. 21 (2024); e41435BEPA. Boletim Epidemiológico Paulista; Vol. 21 (2024); e41435BEPA. Boletim Epidemiológico Paulista ; v. 21 (2024); e414351806-42721806-423Xreponame:BEPA. Boletim epidemiológico paulista (Online)instname:Secretaria de Estado da Saúde de São Paulo (SES-SP)instacron:SESSPporhttps://periodicos.saude.sp.gov.br/BEPA182/article/view/41435/38725Copyright (c) 2024 Adele Caterino-de-Araujoinfo:eu-repo/semantics/openAccessCaterino-de-Araujo, Adele2025-02-14T14:08:14Zoai:ojs.periodicos.saude.sp.gov.br:article/41435Revistahttps://periodicos.saude.sp.gov.br/BEPA182/indexPUBhttps://periodicos.saude.sp.gov.br/BEPA182/oaibepa@saude.sp.gov.br | periodicossp@saude.sp.gov.brhttps://doi.org/10.57148/bepa1806-42721806-423Xopendoar:2025-02-14T14:08:14BEPA. Boletim epidemiológico paulista (Online) - Secretaria de Estado da Saúde de São Paulo (SES-SP)false
dc.title.none.fl_str_mv History of the discovery of the etiological agent of Kaposi’s sarcoma – Human Herpesvirus 8, and the role of the Instituto Adolfo Lutz in researching this infection/ disease
Histórico da descoberta do agente etiológico do sarcoma de Kaposi – Human Herpesvirus 8 e a atuação do Instituto Adolfo Lutz na pesquisa dessa infecção/ doença
title History of the discovery of the etiological agent of Kaposi’s sarcoma – Human Herpesvirus 8, and the role of the Instituto Adolfo Lutz in researching this infection/ disease
spellingShingle History of the discovery of the etiological agent of Kaposi’s sarcoma – Human Herpesvirus 8, and the role of the Instituto Adolfo Lutz in researching this infection/ disease
Caterino-de-Araujo, Adele
KSHV
HHV-8
diagnótico
prevalência
subtipos virais
sarcoma de Kaposi
title_short History of the discovery of the etiological agent of Kaposi’s sarcoma – Human Herpesvirus 8, and the role of the Instituto Adolfo Lutz in researching this infection/ disease
title_full History of the discovery of the etiological agent of Kaposi’s sarcoma – Human Herpesvirus 8, and the role of the Instituto Adolfo Lutz in researching this infection/ disease
title_fullStr History of the discovery of the etiological agent of Kaposi’s sarcoma – Human Herpesvirus 8, and the role of the Instituto Adolfo Lutz in researching this infection/ disease
title_full_unstemmed History of the discovery of the etiological agent of Kaposi’s sarcoma – Human Herpesvirus 8, and the role of the Instituto Adolfo Lutz in researching this infection/ disease
title_sort History of the discovery of the etiological agent of Kaposi’s sarcoma – Human Herpesvirus 8, and the role of the Instituto Adolfo Lutz in researching this infection/ disease
author Caterino-de-Araujo, Adele
author_facet Caterino-de-Araujo, Adele
author_role author
dc.contributor.author.fl_str_mv Caterino-de-Araujo, Adele
dc.subject.por.fl_str_mv KSHV
HHV-8
diagnótico
prevalência
subtipos virais
sarcoma de Kaposi
topic KSHV
HHV-8
diagnótico
prevalência
subtipos virais
sarcoma de Kaposi
description In the year in which we celebrate 30 years since the discovery of the etiological agent of Kaposi's sarcoma (KS), at the time named Kaposi's sarcoma-associated herpesvirus (KSHV), later Human Herpesvirus 8 (HHV-8), the author reports on the role of the Instituto Adolfo Lutz in searching this agent using molecular biology techniques, first in biopsy material stored in paraffin and then in blood, saliva and urine, and in the characterization of subtypes and viral variants of HHV-8 that circulated in patients with KS associated with AIDS (KS-AIDS) in São Paulo, and in indigenous populations from the Brazilian Amazon. Furthermore, in-house serological techniques (indirect immunofluorescence and Western blotting) were standardized using cell lines containing HHV-8 in the latent and lytic phases of viral infection as antigens, and serum or blood collected on filter membrane to search for specific antibodies. The best cost/benefit serological and molecular tests were selected and employed in epidemiological surveys, and HHV-8 prevalence rates were determined in different populations: children, health professionals, individuals with HIV/AIDS, female sex workers, endemic and epidemic KS cases, Amerindians, individuals with chronic renal failure, and the general population of Mozambique. Based on studies related to the pathogenesis of HHV-8 and its association with HIV/AIDS, it was observed that the antiretroviral therapy prevented the emergence of KS-AIDS cases in Brazil and suggested its use to control KS-AIDS in Africa. Finally, HHV-8 infection was confirmed in a case of peripheral effusion lymphoma (PEL). Keywords: KSHV, HHV-8, diagnosis, prevalence, viral subtypes, Kaposi’s sarcoma.
publishDate 2024
dc.date.none.fl_str_mv 2024-12-13
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
Não avaliado pelos pares
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://periodicos.saude.sp.gov.br/BEPA182/article/view/41435
10.57148/bepa.2024.v.21.41435
url https://periodicos.saude.sp.gov.br/BEPA182/article/view/41435
identifier_str_mv 10.57148/bepa.2024.v.21.41435
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://periodicos.saude.sp.gov.br/BEPA182/article/view/41435/38725
dc.rights.driver.fl_str_mv Copyright (c) 2024 Adele Caterino-de-Araujo
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2024 Adele Caterino-de-Araujo
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Coordenadoria de Controle de Doenças - Secretaria de Estado da Saúde de São Paulo
publisher.none.fl_str_mv Coordenadoria de Controle de Doenças - Secretaria de Estado da Saúde de São Paulo
dc.source.none.fl_str_mv BEPA. Boletim Epidemiológico Paulista; Vol. 21 (2024); e41435
BEPA. Boletim Epidemiológico Paulista; Vol. 21 (2024); e41435
BEPA. Boletim Epidemiológico Paulista ; v. 21 (2024); e41435
1806-4272
1806-423X
reponame:BEPA. Boletim epidemiológico paulista (Online)
instname:Secretaria de Estado da Saúde de São Paulo (SES-SP)
instacron:SESSP
instname_str Secretaria de Estado da Saúde de São Paulo (SES-SP)
instacron_str SESSP
institution SESSP
reponame_str BEPA. Boletim epidemiológico paulista (Online)
collection BEPA. Boletim epidemiológico paulista (Online)
repository.name.fl_str_mv BEPA. Boletim epidemiológico paulista (Online) - Secretaria de Estado da Saúde de São Paulo (SES-SP)
repository.mail.fl_str_mv bepa@saude.sp.gov.br | periodicossp@saude.sp.gov.br
_version_ 1838465361196875776